databricks.com

A builder’s guide to scaling Databricks Apps

Scale Databricks Apps from design to production: set latency targets, keep state recoverable, load test, and size instances, ...
STAT

Why the FDA should not approve an ineffective multicancer screening test

Welch is a physician and cancer screening researcher at the Center for Surgery and Public Health at Brigham and Women’s Hospital in Boston. There must be some mistake. A company studies its cancer ...
vercel

What is dependency injection in Python?

Python code becomes harder to test when functions create their own database clients or HTTP sessions. Dependency injection (DI) lets the caller pass those objects into a function or class, so tests ...
Becker's Hospital Review

First multi-cancer blood test nears FDA approval: What to know

An FDA advisory panel voted Sept. 23 in favor of approving Grail’s Galleri multi-cancer early detection blood test, marking the first time a blood test of this kind has reached that stage of review.
vercel

Django vs FastAPI: choosing a Python backend

Django and FastAPI are both common choices when a Python team starts a new backend. Django is the full-stack option, shipping an object-relational mapper (ORM), migrations, authentication, and an ...
Medical Xpress

FDA panel narrowly backs multi-cancer blood test despite doubts it works

A blood test that aims to catch more than 50 types of cancer before symptoms appear narrowly won the backing of U.S. Food and Drug Administration (FDA) advisers Wednesday, even as several doubted it ...
U.S. News & World Report

FDA Panel Narrowly Backs Multi-Cancer Blood Test Despite Doubts It Works

FDA Panel Narrowly Backs Multi-Cancer Blood Test Despite Doubts It Works By Ellyn Vohnoutka HealthDay ReporterTHURSDAY, Sept. 24, 2026 (HealthDay News) — A blood test that aims to catch more than 50 ...
Yahoo

FDA panel endorses GRAIL’s multi-cancer early detection test

A US Food and Drug Administration (FDA) advisory panel has voted in favour of approving GRAIL's Galleri, cuing up a potential landmark approval for the multi-cancer early detection (MCED) test. In ...
Healio

FDA panel: Benefits of Galleri blood test for multicancer detection outweigh risks

Please provide your email address to receive an email when new articles are posted on . The panel voted 7 to 2 with one abstention that the benefits of Galleri outweigh potential risks for multicancer ...
Medical Xpress

PATHFINDER 2 findings advance multi-cancer early detection blood testing

A single blood draw that screens for more than 50 cancers substantially increased cancer detection when added to standard screening, identifying cancers that otherwise might have gone undetected until ...
KLCC

FDA advisory panel recommends a first: multi-cancer blood test

A key advisory committee that reviews medical devices for the Food and Drug Administration recommended the agency approve the first multi-cancer blood test for people 50 and over. Grail, the company ...